Literature DB >> 10818614

The origin and mechanism of circulating DNA.

M Stroun1, P Maurice, V Vasioukhin, J Lyautey, C Lederrey, F Lefort, A Rossier, X Q Chen, P Anker.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10818614     DOI： 10.1111/j.1749-6632.2000.tb06608.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  110 in total

1.  Plasma DNA restoration for PCR applications.

Authors:  Y R Arias; E F Carrillo; F A Aristizábal
Journal:  J Clin Pathol       Date:  2007-08       Impact factor: 3.411

Review 2.  Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.

Authors:  Bert Gold; Milena Cankovic; Larissa V Furtado; Frederick Meier; Christopher D Gocke
Journal:  J Mol Diagn       Date:  2015-05       Impact factor: 5.568

Review 3.  Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer.

Authors:  Paola Ulivi; Rosella Silvestrini
Journal:  Cell Oncol (Dordr)       Date:  2013-11-01       Impact factor: 6.730

4.  Clinical Utility of Non-Invasive Prenatal Screening from Maternal Blood.

Authors:  Viorica Radoi; Camil Bohiltea; Roxana Bohiltea; Monica Cirstoiu
Journal:  Maedica (Bucur)       Date:  2015-09

5.  A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine.

Authors:  Selena Y Lin; Veerpal Dhillon; Surbhi Jain; Ting-Tsung Chang; Chi-Tan Hu; Yih-Jyh Lin; Shun-Hua Chen; Kung-Chao Chang; Wei Song; Lixin Yu; Timothy M Block; Ying-Hsiu Su
Journal:  J Mol Diagn       Date:  2011-07-02       Impact factor: 5.568

Review 6.  Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA).

Authors:  Re-I Chin; Kevin Chen; Abul Usmani; Chanelle Chua; Peter K Harris; Michael S Binkley; Tej D Azad; Jonathan C Dudley; Aadel A Chaudhuri
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

Review 7.  Cell-free nucleic acids as biomarkers in cancer patients.

Authors:  Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2011-05-12       Impact factor: 60.716

Review 8.  Improving Cancer Detection and Treatment with Liquid Biopsies and ptDNA.

Authors:  Michael D Kessler; Nisha R Pawar; Stuart S Martin; Toni M Antalis; Timothy D O'Connor
Journal:  Trends Cancer       Date:  2018-08-01

Review 9.  Biophysical technologies for understanding circulating tumor cell biology and metastasis.

Authors:  Derrick W Su; Jorge Nieva
Journal:  Transl Lung Cancer Res       Date:  2017-08

10.  Multianalyte tests for the early detection of cancer: speedbumps and barriers.

Authors:  Michael A Tainsky; Madhumita Chatterjee; Nancy K Levin; Sorin Draghici; Judith Abrams
Journal:  Biomark Insights       Date:  2007-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.